Patterson-UTI Energy (NASDAQ:PTEN) was upgraded by analysts at Goldman Sachs from a “neutral” rating to a “conviction-buy” rating in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports. Patterson-UTI Energy, Inc. (NASDAQ:PTEN) stock opened today at $30.05 and is currently trading at $30.28. The stock showed a negative weekly performance of -1.20%.
STAAR Surgical Company (Nasdaq:STAA) reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration’s (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes recommendations to the Commissioner of Food and Drugs. STAAR Surgical Company (NASDAQ:STAA) stock opened at $17.99, in current trading session and currently is at $19.50, by gaining 20.36%.The 52 week range of $5.27-$19.50.Company’s market capitalization is $702.39 million.
Lorillard (NYSE:LO) was upgraded by equities researchers at Goldman Sachs from a “neutral” rating to a “buy” rating in a research report issued on Monday, TheFlyOnTheWall.com reports. The firm currently has a $60.00 target price on the stock. Goldman Sachs’ price objective would suggest a potential upside of 15.70% from the stock’s previous close.Lorillard Inc. (NYSE:LO) stock is currently trading at $53.01 .The EPS of the stock is 3.22.Company’s market capitalization is $19.23 billion.
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by stock analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating in a report issued on Monday, TheFlyOnTheWall.com reports.Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stock opened the session at $336.06, and now is at $337.00. The 52 week range of the REGN stock remained $168.20-$352.49 and the day range was $331.16-$337.00.